Regenxbio Inc (RGNX)
Pretax margin
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) (ttm) | US$ in thousands | -263,646 | -260,583 | -274,199 | -270,317 | -280,405 | 86,999 | 104,078 | 114,618 | 141,247 | -206,677 | -139,484 | -116,107 | -106,010 | -94,367 | -137,904 | -105,228 | -97,348 | -62,566 | -48,311 | -32,281 |
| Revenue (ttm) | US$ in thousands | 85,585 | 89,565 | 82,833 | 89,765 | 89,470 | 395,745 | 424,505 | 432,813 | 446,605 | 134,740 | 275,433 | 273,347 | 271,089 | 261,412 | 95,283 | 71,153 | 44,415 | 73,424 | 54,848 | 86,998 |
| Pretax margin | -308.05% | -290.94% | -331.03% | -301.14% | -313.41% | 21.98% | 24.52% | 26.48% | 31.63% | -153.39% | -50.64% | -42.48% | -39.11% | -36.10% | -144.73% | -147.89% | -219.18% | -85.21% | -88.08% | -37.11% |
December 31, 2023 calculation
Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $-263,646K ÷ $85,585K
= -308.05%
Regenxbio Inc's pretax margin has experienced significant fluctuations over the past eight quarters. The company's pretax margin has been negative, ranging from -292.15% to -246.54% in the last four quarters of 2023, indicating that the company's operating expenses and losses have exceeded its revenue during those periods.
Comparing to the data from 2022, where the pretax margin was positive in the last two quarters, the decline in pretax margin in 2023 raises concerns about the company's profitability and operational efficiency. This downward trend may be a result of increased expenses, lower revenue generation, or a combination of both factors.
Analyzing the pretax margin data suggests that Regenxbio Inc may be facing challenges in managing costs and generating sufficient revenue to cover its expenses. Investors and stakeholders may seek further information on the company's cost structure, revenue streams, and operational strategies to understand the factors contributing to the negative pretax margins and assess the company's financial health and performance.
Peer comparison
Dec 31, 2023